Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIA-N2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04926831
What this trial is testing

Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04062708
What this trial is testing

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
Alliance Foundation Trials, LLC. 38
Testing effectiveness (Phase 2)Study completedNCT00103051
What this trial is testing

Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT00030771
What this trial is testing

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Who this might be right for
Lung Cancer
Swiss Cancer Institute 232
Testing effectiveness (Phase 2)Study completedNCT00198367
What this trial is testing

Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Hospices Civils de Lyon 120
Testing effectiveness (Phase 2)UnknownNCT01187290
What this trial is testing

Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Jiao Tong University School of Medicine 80
Testing effectiveness (Phase 2)Study completedNCT00005868
What this trial is testing

Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 47
Testing effectiveness (Phase 2)UnknownNCT04965831
What this trial is testing

Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)

Who this might be right for
Lung Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Large-scale testing (Phase 3)UnknownNCT01407822
What this trial is testing

Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 72
Large-scale testing (Phase 3)Active Not RecruitingNCT06077760
What this trial is testing

Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 868
Not applicableUnknownNCT02555592
What this trial is testing

Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level

Who this might be right for
Lung CancerCancer of Lymph NodeEffects of Chemotherapy+1 more
Pusan National University Hospital 25
Large-scale testing (Phase 3)Ended earlyNCT00273507
What this trial is testing

Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3

Who this might be right for
Non-small Cell Lung Cancer
Rigshospitalet, Denmark 270
Large-scale testing (Phase 3)Looking for participantsNCT06431633
What this trial is testing

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Who this might be right for
Lung DiseasesCarcinoma, Non-Small-Cell LungResectable Lung Non-Small Cell Carcinoma
Fundación GECP 129
Large-scale testing (Phase 3)Study completedNCT00002550
What this trial is testing

Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 429
Testing effectiveness (Phase 2)Ended earlyNCT00063258
What this trial is testing

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)UnknownNCT01771289
What this trial is testing

Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Peking University People's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00006469
What this trial is testing

Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Medstar Health Research Institute 30
Testing effectiveness (Phase 2)UnknownNCT01926483
What this trial is testing

Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection

Who this might be right for
Non-small Cell Lung Cancer Stage IIIA
Zhejiang Cancer Hospital 75
Early research (Phase 1)Study completedNCT01854684
What this trial is testing

Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung CarcinomaStage IIB Non-Small Cell Lung Carcinoma+2 more
Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT00600587
What this trial is testing

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Guangdong Provincial People's Hospital 24
Next Page